Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. Summary
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
Real-time Estimate Cboe Europe  -  06:57 2022-10-04 am EDT
76.96 CHF   +1.29%
10/03Imugene Names Chief Medical Officer; Shares Rise 3%
MT
09/29Moderna Adds New Role Ahead of Product Launches
DJ
09/28Pm(noc) Regulations : Five-year Anniversary Of Major Amendments
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

NOVARTIS REPORTS TWO CHILDREN DIED FROM ACUTE LIVER FAILURE AFTE…

08/11/2022 | 04:03pm EDT

NOVARTIS REPORTS TWO CHILDREN DIED FROM ACUTE LIVER FAILURE AFTER TREATMENT WITH ITS ZOLGENSMA GENE THERAPY - STAT NEWS


© Reuters 2022
All news about NOVARTIS AG
10/03Imugene Names Chief Medical Officer; Shares Rise 3%
MT
09/29Moderna Adds New Role Ahead of Product Launches
DJ
09/28Pm(noc) Regulations : Five-year Anniversary Of Major Amendments
AQ
09/28Europe's generic drugmakers say they may cut output due to energy bills
RE
09/28Europe's generic drugmakers may cut output due to surging energy bills
RE
09/27Monsenso participates in new, large innovation project
AQ
09/27Europe's generic drugmakers may cut output due to surging energy bills
RE
09/27Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Exten..
AQ
09/26NOVARTIS AG : UBS reiterates its Neutral rating
MD
09/23NOVARTIS AG : Deutsche Bank gives a Sell rating
MD
More news
Analyst Recommendations on NOVARTIS AG
More recommendations
Financials (USD)
Sales 2022 52 240 M - -
Net income 2022 8 932 M - -
Net Debt 2022 8 452 M - -
P/E ratio 2022 18,8x
Yield 2022 4,30%
Capitalization 167 B 167 B -
EV / Sales 2022 3,36x
EV / Sales 2023 3,31x
Nbr of Employees 108 000
Free-Float 87,1%
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 25
Last Close Price 76,61 $
Average target price 90,00 $
Spread / Average Target 17,5%
EPS Revisions
Managers and Directors
Vasant Narasimhan Chief Executive Officer
Harry Werner Kirsch Chief Financial Officer
Hans Jörg Reinhardt Non-Executive Chairman
Shreeram Aradhye Chief Medical Officer
Steffen Lang President-Operations
Sector and Competitors
1st jan.Capi. (M$)
NOVARTIS AG-5.36%167 230
JOHNSON & JOHNSON-4.60%429 082
ELI LILLY AND COMPANY17.06%305 529
ROCHE HOLDING AG-15.04%267 122
PFIZER, INC.-25.25%247 729
ABBVIE INC.2.16%244 563